Splenomegaly impacts prognosis in essential thrombocythemia and polycythemia vera: A single center study

Simona Raso, Sergio Siragusa, Antonio Russo, Alessandro Perez, Marco Santoro, Sergio Siragusa, Paolo Casimiro, Angelo Davide Contrino, Vincenzo Accurso, Florinda Di Piazza, Paolo Casimiro

Risultato della ricerca: Articlepeer review

11 Citazioni (Scopus)

Abstract

Splenomegaly is one of the major clinical manifestations of primary myelofibrosis and is common also in other chronic Philadelphia-negative myeloproliferative neoplasms, causing symptoms and signs and affecting quality of life of patients diagnosed with these diseases. We aimed to study the impact that such alteration has on thrombotic risk and on the survival of patients with essential thrombocythemia and patients with Polycythemia Vera (PV). We studied the relationship between splenomegaly (and its grade), thrombosis and survival in 238 patients with et and 165 patients with PV followed at our center between January 1997 and May 2019.
Lingua originaleEnglish
pagine (da-a)95-97
Numero di pagine3
RivistaHematology Reports
Volume11
Stato di pubblicazionePublished - 2019

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2720???

Fingerprint

Entra nei temi di ricerca di 'Splenomegaly impacts prognosis in essential thrombocythemia and polycythemia vera: A single center study'. Insieme formano una fingerprint unica.

Cita questo